- 分類：R & D
- 發佈時間：2019-06-18 00:00:00
The company always adheres to the development concept of "technology first, quality first, standard leading and management science",Guided by product innovation, focusing on the introduction and training of talents, we have a high-level R & D team with reasonable structure, highly professional and rich experience,It has good technology accumulation in catalytic selective oxidation, high-pressure hydrogenation, diazotization, alkylation, fluorination, Grignard reaction and other reaction types, and can provide the service of pharmaceutical intermediates and APIs from small test, pilot test to commercial scale-up production.It can provide services for pharmaceutical intermediates and APIs from small and medium-sized trials to commercial scale-up production.
The R & D of Zhenlei chemical industry focuses on the product group positioning of stomach medicine, diabetes medicine, anticancer medicine and other fields, focusing on pesticide, dye and other fields, focusing on the green new process development of strategic intermediates of important varieties. In terms of new drug R & D, technological process optimization and upgrading, product quality control and other aspects, it has achieved breakthroughs in process technology and quality control technology and ensured the enterprise R & D capability and quality management level of original new drugs. Gradually achieve the goal of creating an international pharmaceutical enterprise with outstanding value creation ability, and make China Pharmaceutical recognized by the world!